title: Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.
abstract: Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.
authors.affiliation: Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Department of Medicine, Seattle, USA.
authors.forename: William Y
authors.initials: WY
authors.lastname: Ho
authors.forename: Joseph N
authors.initials: JN
authors.lastname: Blattman
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Dossett
authors.forename: Cassian
authors.initials: C
authors.lastname: Yee
authors.forename: Philip D
authors.initials: PD
authors.lastname: Greenberg
mesh_terms: D000818:Animals; D000918:Antibody Specificity; D017951:Antigen Presentation; D002470:Cell Survival; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008954:Models, Biological; D009369:Neoplasms / Q000628:therapy*; D017434:Protein Structure, Tertiary; D013601:T-Lymphocytes / Q000276:immunology*